Colorado 2026 Regular Session

Colorado Senate Bill SJR26014

Caption

Concerning the declaration of February 28, 2026, as Rare Disease Day.

Summary

SJR26-014 is a Colorado Senate Joint Resolution that designates February 28, 2026, as Rare Disease Day in Colorado. The resolution is largely commemorative and declaratory: it recites findings about the prevalence, cost, and difficulty of living with rare diseases, highlights the challenges faced by patients and families in obtaining diagnosis and treatment, and recognizes the work of advocates and organizations supporting rare disease awareness. The resolution also encourages Coloradans and lawmakers to “show our stripes” in solidarity with people living with rare diseases, and it directs that copies of the resolution be sent to the Colorado Rare Disease Advisory Council. It does not create a new regulatory program, funding source, or substantive health-care mandate; instead, it serves as an official legislative recognition and awareness measure.

Impact

Because this is a joint resolution rather than a bill amending the Colorado Revised Statutes, it does not directly change state law or impose legal obligations on agencies, providers, insurers, or patients. Its practical effect is symbolic and promotional: it formally establishes a state observance, elevates public awareness of rare diseases, and acknowledges the Colorado Rare Disease Advisory Council and affected communities.

Sentiment

The sentiment around the resolution is strongly supportive and bipartisan. The sponsorship list is broad, and the text itself is affirming and sympathetic toward individuals and families affected by rare diseases. The resolution frames the issue as one of compassion, awareness, and recognition, with no evidence of opposition in the provided voting or committee materials.

Contention

No notable substantive contention is reflected in the available materials. Because the measure is ceremonial, there is no apparent disagreement over policy design, costs, or regulatory impact. The only implicit policy theme is the broader need for better access to care, diagnosis, and treatment for rare disease patients, but the resolution itself does not attempt to resolve those issues.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.